Aims-To determine the role of insulinlike growth factors (IGF) in the proliferation of tumour cells, by studying the mitogenic response to IGFs of three cell lines of differing phenotype established from both malignant rhabdoid and Wilms tumour, representing a range of cell types (GOS 4, G401, and T3/73). Methods-Production ofIGF-II and IGF-I was measured by radioimmunoassay, and the presence of IGF binding protein complexes was observed by gel exclusion chromatography. Following growth analyses in serum-free media to ascertain the dependence of the cell lines on exogenous IGFs, the generation of autocrine growth was measured by a density dependence assay ofproliferation in culture. Receptors were measured by radioligand cross linking and autocrine growth through these receptors assayed by the use of blocking antibodies. Results-While GOS 4 and G401 were able to proliferate in serum-free medium over a period of 5 d, T3/73 showed an absolute dependence on IGFs added daily at 1-10 ng/ml. Plating at clonal density showed that cell growth was directly density dependent in serum-free medium. The serum independent proliferation of G401 and GOS 4 was blocked by the addition of an antibody to the type 1 IGF receptor (a-IR3) suggesting that the effects of autocrine factors are mediated through type 1 IGF receptors. SI nuclease protection analysis indicated that all three cell lines produced significant amounts of mRNA derived mainly from the P3 IGF-II promoter, but transcripts for IGF-I were undetectable. Radioimmunoassay of IGFs from conditioned media showed that all the lines made assayable , and 6-1 ng/mll24 h/106 cells for GOS 4, G401, and T3/73 respectively). The presence of species consistent with both type 1 and type II IGF receptors was demonstrated using radioligand binding to cell membranes followed by cross linking. Conclusions-Autocrine IGF-II may contribute to the serum independence of GOS 4 and G401 cells, whereas T3/73 may depend on exogenous IGF-II for proliferation. (7 Clin Pathol: Mol Pathol 1995;48:M333-M341) 
Both Wilms tumour and renal malignant rhabdoid tumours are believed to be derived from aberrations in the genesis of normal differentiated kidney tissues during development.' Wilms tumour is an embryonal neoplasm of childhood which is thought to originate in delayed or abnormal differentiation of cells from the metanephric blastema,2 while malignant rhabdoid tumour, originally classified as a rhabdomyosarcomatoid variant of Wilms tumour, is a very aggressive tumour believed to arise from more primitive mesodermal precursors. 3 While Wilms tumour suppressor gene (WT-1) and other loci have been implicated in Wilms tumorigenesis, this gene codes for a zinc finger containing transcription factor, and it has therefore become of great interest to look for factors downstream of WT-1, in which altered regulation may cause the growth aberration characteristic of this tumour. One candidate factor is insulin-like growth factor II (IGF-II). IGF-II is a 67 amino acid peptide hormone, a member of the insulin related family of peptide growth factors which includes IGF-I, relaxin, and insulin itself. The biological actions of insulin, IGF-I, and IGF-II are mediated through at least three receptors and modulated by the action of a family of six IGF binding proteins, which may act either to inhibit or to potentiate the action of the peptide hormones (for general reviews see 4) . It is interesting to note that a common cytogenetic lesion in malignant rhabdoid tumours is between D 1 1 S 12 and TH at I1 p 1 5,5 a region also thought to be involved in the overgrowth and tumour predisposing Beckwith-Wiedemann syndrome, often associated with IGF-II overexpression. 6 IGF-I and IGF-II are thought to be pivotal in embryonic growth and differentiation, including the development of the metanephric kidney.7 IGF-II is expressed at high levels in the metanephric blastema during nephrogenesis and has been shown to be important in blastemal cell growth in kidney organ culture. 8 After birth, levels of IGF-II transcription drop 50-100 fold. Examination of the expression of the IGF genes in a variety of pathological processes9 indicates that kidney IGF-II is only increased in embryonal nephroblastoma (Wilms tumour) where the gene can be massively activated to levels only seen during development. [10] [11] [12] We have tried to approach the question of the role of IGF-II in tumours by examining the production and response to IGF-II in cell lines derived from childhood kidney tumours. Three cell lines were selected which show distinct characteristics. G40 125 is a highly malignant epithelioid tumour, used much in the study of tumour suppression by WT-1. Garvin et al26 have suggested that it is most close in phenotype to malignant rhabdoid tumour, on the basis of the study of tumour cells passaged through a nude mouse. However, selection for higher grade malignancy by in vivo passage cannot be ruled out. GOS 4 was derived from a primary rhabdomyosarcomatoid Wilms tumour, later reclassified as malignant rhabdoid tumour, and gives rise to characteristic small cell tumours in xenograft culture. In culture the cells are mainly cytokeratin negative as might be expected for more primitive nephrogenic stem cells27 28; however, cytokeratin positive cells arise in the clonal population sporadically (Schofield PN, unpublished data). The cells are N-CAM negative and express desmin weakly. T3/73 was established from a primary Wilms tumour with heterologous differentiation29 and is much more mesenchymal in morphology, being 95% desmin positive and only 5% cytokeratin positive. It has never been shown to give rise to tumours in nude mice even at high inocula.
We show here that G401 and GOS 4 can grow in serum-free media through the generation of autocrine IGF-II. T3/73, however, makes insufficient IGF-II to complete an autocrine loop successfully. These results suggest that production of IGF-II by populations of cells in malignant rhabdoid tumours may be responsible for tumour cell proliferation or survival and also indicates that paracrine mech- 
MEASUREMENT OF IGF-I AND IGF-II PEPTIDES
Collection of conditioned medium was made in the same way as described in Schofield et al": 2 x 106 cells were plated in T175 tissue culture flasks (Nunc, Gibco) and when the cells approached but did not reach confluence they were washed five times in prewarmed medium, after which 15 ml of serum-free medium was added; after 18 h, medium was aspirated, centrifuged at 180 x g for 20 min to remove debris, and frozen at -70°C.
An aliquot of 10 ml conditioned medium derived from Wilms tumour cell lines as described above was freeze dried, reconstituted in 250 gl of 2 M acetic acid, and loaded onto a Sephacryl S-200 HR column (30 x 1 cm; Pharmacia) equilibrated with 1 M acetic acid, pH 4.0. Fractions (1 ml) were collected and aliquots of 250,l freeze dried. Fractions equivalent to a Kd between 0-82 and 0 95 (for IGF-I and IGF-II) and 0-69-0-77 (for high molecular weight forms) were analysed by radioimmunoassay. IGF-I was measured as described"6 using recombinant IGF-I (KaBi Pharmacia) as standard. Cross reaction of IGF-II was less than 1 %. IGF-II was measured similarly using a monoclonal antibody to IGF-II (MAS 324, clone S1-F2) (Seralab) and recombinant IGF-II (KaBi Pharmacia AB) as standard. Each vial contained 10 ig of IgG and was reconstituted in 1 ml of buffer. The initial dilution of the stock solution added to the assay was 1:6000. Cross reactivity for IGF-II in the IGF-I assay was 1-4%. Iodinated human IGFBP-1 purified from human plasma was the kind gift of Dr D Morrell.
Results

PROLIFERATION OF CELL LINES AT CLONAL DENSITY
In order to examine the potential for autocrine growth of the cell lines under investigation we assessed the effects of cell density on clonal proliferation. Should an autocrine factor be rate limiting on cell division or survival we would expect to see a density dependence of proliferation. Cells were plated at differing clonal densities as described in Methods, allowed to grow for 7 Radioimmunoassay of IGF-II in conditioned medium from Wilms tumour cell lines. Conditioned media were subjected to either an acid (pH 4) or a neutral (pH 7 4) gelfiltration column as described in Methods; 1 ml fractions were freeze dried and IGF-II was radioimmunoassayed. 
